Literature DB >> 17896906

Antimicrobial stewardship.

Michael J Rybak1.   

Abstract

In response to the global antibiotic resistance crisis, antimicrobial stewardship programs have emerged throughout the United States. Effective programs integrate several strategic methods, including evaluation and feedback regarding the necessity and appropriateness of antimicrobial therapy, staff education, and formulary restrictions. Multidisciplinary teams as well as institutional support are needed to form effective subcommittees to monitor national and local surveillance reports and resistance patterns, and to update antibiograms. Computerized decision support programs have been effective and successful methods of antimicrobial stewardship and can be a powerful tool in stewardship programs. Successful programs have reduced not only institutional resistance rates, but also morbidity, mortality, and cost.

Mesh:

Substances:

Year:  2007        PMID: 17896906     DOI: 10.1592/phco.27.10part2.131S

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  4 in total

Review 1.  Optimization of antibiotic use in hospitals--antimicrobial stewardship and the EU project ABS international.

Authors:  Franz Allerberger; Arno Lechner; Agnes Wechsler-Fördös; Roland Gareis
Journal:  Chemotherapy       Date:  2008-07-31       Impact factor: 2.544

Review 2.  Antibiotic stewardship through the EU project "ABS International".

Authors:  Franz Allerberger; Annegret Frank; Roland Gareis
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  Impact of dose de-escalation and escalation on daptomycin's pharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitro model.

Authors:  Celine Vidaillac; Molly E Steed; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2011-02-14       Impact factor: 5.191

Review 4.  Preventing healthcare-associated infection: risks, healthcare systems and behaviour.

Authors:  J K Ferguson
Journal:  Intern Med J       Date:  2009-09       Impact factor: 2.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.